Immunsys, Inc.

Also on record

Records under this name other than the patents Immunsys, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 2 of 2 · Back to Immunsys, Inc.

Patent	Title	Status	Expires	Confidence
US 10,849,678	Cancer Immunotherapy by Radiofrequency Electrical Membrane Breakdown (RF-EMB) Formerly held In force Ends no later than Jan 3, 2036 · Low confidence	In force	Ends no later than Jan 3, 2036	Low confidence
US 11,497,544	Immunologic Treatment of Cancer Formerly held In force Term ends Jan 13, 2037 · High confidence	In force	Term ends Jan 13, 2037	High confidence